# US 2024/0002927 A1 · Methods for detection of nucleotide modification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002927 A1
- Document ID: US20240002927A1
- Status: Published application
- Kind: A1
- Application number: 18/313,146
- Filed: 2023-05-05
- Published: 2024-01-04
- Earliest claimed: 2020-11-09
- Assignees: Bluecat IP Limited
- Applicants: Bluecat IP Limited
- Inventors: Shankar BALASUBRAMANIAN; Ben MORTISHIRE-SMITH; Sidney BECKER
- Web page: https://patentgrep.com/patent/US20240002927A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 2600/154: Methylation markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention provides a method of identifying a modified cytosine residue in a polynucleotide. The method includes the steps of reducing and deaminating a 5-methylcytosine residue within the polynucleotide and sequencing the polynucleotide, such that the location of the modified cytosine residue can be identified. The invention also provides a method of identifying a 5-methylcytosine residue, a 5-carboxylcytosine residue or a nucleotide in a polynucleotide. The method involves treating the polynucleotide with a radical initiator. The presence of the 5-methylcytosine residue, 5-carboxylcytosine residue or nucleotide can be identified as a residue such as thymine detected by sequencing of the treated polynucleotide. Also provided is a method of converting a 5-methylcytosine residue in a polynucleotide to a dihydrothymine residue, and use of a radical initiator to convert a 5-methylcytosine residue in a polynucleotide to a dihydrothymine residue, or to convert a 5-carboxylcytosine residue to a dihydrouracil residue.

## Claims

### Claim 1

A method of identifying a modified cytosine residue in a sample nucleotide sequence, the method comprising;
(i) providing a population of polynucleotides which comprise the sample nucleotide sequence,
(ii) reducing and deaminating a 5-methylcytosine (5mC) residue within the population,
(iii) sequencing the polynucleotides in the population or derivatives thereof following step (ii) to produce a treated nucleotide sequence, and;
(iv) identifying the residue in the treated nucleotide sequence which corresponds to a modified cytosine residue in the sample nucleotide sequence.

### Claim 2 (depends on 1)

The method of claim 1, wherein the reduction is the reduction of the C5-C6 bond in a modified cytosine residue, and the deamination is the loss of the amino group at the C4 position in a modified cytosine residue, which is replaced with hydroxyl.

### Claim 3 (depends on 1)

The method of claim 1, wherein the presence of a thymine residue in the treated nucleotide sequence is indicative that the modified cytosine residue in the sample nucleotide sequence is 5-methylcytosine (5mC).

### Claim 4

A method of identifying 5-methylcytosine (5mC) or 5-carboxylcytosine (5caC) in a sample nucleotide sequence, the method comprising:
(i) providing a population of polynucleotides which comprise the sample nucleotide sequence,
(ii) treating the population with a radical initiator together with a nucleophile,
(iii) sequencing the polynucleotides in the population or derivatives thereof following step (ii) to produce a treated nucleotide sequence, and;
(iv) identifying the residue in the treated nucleotide sequence which corresponds to a modified cytosine residue in the sample nucleotide sequence,
wherein the presence of a thymine residue in the treated nucleotide sequence is indicative that the modified cytosine residue in the sample nucleotide sequence is 5-methylcytosine (5mC) or 5-carboxylcytosine (5caC).

### Claim 5

A method of identifying a modified cytosine residue in a sample nucleotide sequence, the method comprising:
(i) providing a population of polynucleotides which comprise the sample nucleotide sequence,
(ii) oxidising a first portion of said population,
(iii) treating the oxidised first portion of said population with a radical initiator together with a nucleophile, sequencing the polynucleotides in the first portions of the population or derivatives thereof following steps ii) and iii) to produce a first nucleotide sequence, and;
(iv) identifying the residue in the first nucleotide sequences which corresponds to a modified cytosine residue in the sample nucleotide sequence.

### Claim 6 (depends on 5)

The method of claim 5, wherein in step (ii), the oxidation is the oxidation of a C5 methyl group in a modified cytosine residue.

### Claim 7 (depends on 5)

The method of claim 5, wherein the oxidation is an oxidation by a ten-eleven-translocation (TET) oxygens.

### Claim 8

A method for modifying a polynucleotide, the method comprising converting a 5-methylcytosine (5mC) residue in a polynucleotide to a dihydrothymine (DHT) residue by contacting the 5mc residue with a radical initiator and a nucleophile compound.

### Claim 9

(canceled)

### Claim 10 (depends on 8)

The method according claim 8, wherein the radical initiator is a transition metal photocatalyst.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the transition metal photocatalyst.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the transition metal photocatalyst comprises [Ir(dF(CF3)ppy)2(dtbpy)]+.

### Claim 13 (depends on 1)

The method according to claim 1, wherein the nucleophile is a thiol compound, and/or the disulfide form thereof.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the thiol compound has one, two or three thiol groups, and the thiol compound has one, two or three hydroxyl groups.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the thiol is an alkyl thiol.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the thiol is mercaptoethanol.

### Claim 17 (depends on 5)

The method according to claim 5, wherein, in step (ii), the first portion of the polynucleotide is treated with a ten-eleven translocation (TET) dioxygenase.

### Claim 18 (depends on 1)

The method according to claim 1, wherein the polynucleotides are genomic DNA.

### Claim 19 (depends on 1)

The method according to claim 1, wherein the polynucleotides are RNA.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the RNA is genomic RNA, mRNA, tRNA, rRNA or non-coding RNA.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

A kit for identifying a modified cytosine residue comprising:
(a) a radical initiator, comprising [Ir(dF(CF3)ppy)2(dtbpy)]Cl; and
(b) a nucleophile, comprising a thiol compound.

### Claim at position 25

25-50. (canceled)
